Tianjin Pharmaceutical Da Ren Tang Group to Host Online Briefing on Interim Results

SGX Filings

Yesterday

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited said on Aug, 26 2026 that it will hold an online investor conference on Sep, 03 2026 to discuss its unaudited financial results for the six months ended Jun, 30 2026.

The session will run from 3:00 p.m. to 5:00 p.m. (Beijing time) via the rs.p5w.net platform, using a remote network format. Chairperson Wang Lei, Executive Deputy General Manager Chen Hong, Chief Financial Officer Ma Jian and Board Secretary Jiao Yan will represent the company.

The interim results were released on Aug, 14 2026 through the Singapore Exchange website. Investors may submit questions in advance by emailing drt600329@163.com before 5:00 p.m. on Aug, 31 2026, or participate live during the event.

Contact details for further inquiries are available from Zhao Liyang or Jiang Ling at +86-22-27020892. A replay of the briefing will be accessible on rs.p5w.net after the event.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://nz.tigrwd.com/news/1194783449"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1194783449\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1194783449?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-26 18:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1194783449","market":"sg","top_or_hot":-1,"title":"Tianjin Pharmaceutical Da Ren Tang Group to Host Online Briefing on Interim Results","media":"SGX Filings","content":"\n<p>Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited said on Aug, 26 2026 that it will hold an online investor conference on Sep, 03 2026 to discuss its unaudited financial results for the six months ended Jun, 30 2026.</p>\n<p>The session will run from 3:00 p.m. to 5:00 p.m. (Beijing time) via the rs.p5w.net platform, using a remote network format. Chairperson Wang Lei, Executive Deputy General Manager Chen Hong, Chief Financial Officer Ma Jian and Board Secretary Jiao Yan will represent the company.</p>\n<p>The interim results were released on Aug, 14 2026 through the Singapore Exchange website. Investors may submit questions in advance by emailing drt600329@163.com before 5:00 p.m. on Aug, 31 2026, or participate live during the event.</p>\n<p>Contact details for further inquiries are available from Zhao Liyang or Jiang Ling at +86-22-27020892. A replay of the briefing will be accessible on rs.p5w.net after the event.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tianjin Pharmaceutical Da Ren Tang Group to Host Online Briefing on Interim Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTianjin Pharmaceutical Da Ren Tang Group to Host Online Briefing on Interim Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1083912268\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">SGX Filings </p>\n<p class=\"h-time\">2026-08-26 18:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n\n<p>Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited said on Aug, 26 2026 that it will hold an online investor conference on Sep, 03 2026 to discuss its unaudited financial results for the six months ended Jun, 30 2026.</p>\n<p>The session will run from 3:00 p.m. to 5:00 p.m. (Beijing time) via the rs.p5w.net platform, using a remote network format. Chairperson Wang Lei, Executive Deputy General Manager Chen Hong, Chief Financial Officer Ma Jian and Board Secretary Jiao Yan will represent the company.</p>\n<p>The interim results were released on Aug, 14 2026 through the Singapore Exchange website. Investors may submit questions in advance by emailing drt600329@163.com before 5:00 p.m. on Aug, 31 2026, or participate live during the event.</p>\n<p>Contact details for further inquiries are available from Zhao Liyang or Jiang Ling at +86-22-27020892. A replay of the briefing will be accessible on rs.p5w.net after the event.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"T14.SI","symbol_name":"达仁堂","start_time":0,"source_url":"","article_id":"1194783449","we_media_id":"1083912268","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1194783449","pubTimestamp":1787738929,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"SGX Filings","introduction":"Fastest News on SGX Filings ","home_visible":1,"id":"1083912268","head_image":"https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39"},"summary":"Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited said on Aug, 26 2026 that it will hold an online investor conference on Sep, 03 2026 to discuss its unaudited financial results for the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"T14.SI":"达仁堂"},"translate_title":"天津医药大仁堂集团将举办中期业绩在线说明会","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"T14.SI":1},"content_text":"Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited said on Aug, 26 2026 that it will hold an online investor conference on Sep, 03 2026 to discuss its unaudited financial results for the six months ended Jun, 30 2026.\nThe session will run from 3:00 p.m. to 5:00 p.m. (Beijing time) via the rs.p5w.net platform, using a remote network format. Chairperson Wang Lei, Executive Deputy General Manager Chen Hong, Chief Financial Officer Ma Jian and Board Secretary Jiao Yan will represent the company.\nThe interim results were released on Aug, 14 2026 through the Singapore Exchange website. Investors may submit questions in advance by emailing drt600329@163.com before 5:00 p.m. on Aug, 31 2026, or participate live during the event.\nContact details for further inquiries are available from Zhao Liyang or Jiang Ling at +86-22-27020892. A replay of the briefing will be accessible on rs.p5w.net after the event.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}